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Abstract Tissue-type plasminogen activator (tPA) secretion is a specific response of Sertoli cells to follicle-stimulating hormone (FSH), which is 
lower after preincubation of the cells with low FSH concentrations because of FSH receptor/G, protein uncoupling. In this report, we present evidence 
that this desensitization induced by the lowest FSH concentrations is suppressed by specific peptidic inhibitors of endogenous PKA and PKC in 
permeabilized Sertoli cells. In contrast, desensitization promoted by slightly higher FSH concentrations is not mediated through PKA or PKC 
activation but is dependent on protein neosynthesis. 
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1. Introduction 
Hormone stimulation usually leads to subsequent desensiti- 
zation of their target cells towards the same hormone (homol- 
ogous desensitization) and sometimes also towards other 
hormones (heterologous desensitization). These alterations of 
cell responsiveness are mediated by a combination of different 
mechanisms occuring over different time scales, ranging from 
seconds to days. Two main forms of cell desensitization have 
been identified at the level of the first steps of the hormonal 
transduction pathway. Slow mechanisms (hours to days) in- 
volve alteration in receptor synthesis and degradation. This 
degradation after internalization is known as down-regulation 
and is provoked by rather high concentrations of hormone. 
Rapid mechanisms (seconds to hours) include functional un- 
coupling between receptors and the G, proteins, usually due to 
phosphorylation of one or both of these molecules. 
We have previously demonstrated [l] that low follicle-stimu- 
lating hormone (FSH) concentrations (0.3-5 ng/ml) inhibit by 
70% the subsequent issue-type plasminogen activator (tPA) 
response of Sertoli cells to a submaximal dose of hormone (100 
r&ml) over a time lag of 2.5 h. This desensitization process 
implies uncoupling of the FSH receptor and the G, protein, the 
likely site of the lesion being the FSH receptor. This uncoupling 
is in agreement with several previous reports on the desensitiza- 
tion by FSH of Sertoli cell responses [2-51. 
Desensitization of Sertoli cell tPA response can also be in- 
duced, but to a weaker extent, by another ligand such as the 
/?-adrenergic agonist, isoproterenol, as well as by CAMP ana- 
logs (PKA activators) or phorbol esters (PKC activators). 
By cross-checking all these observations, we hypothesize that 
two different mechanisms might be involved in FSH-induced 
desensitization of tPA response: first, one triggered by ex- 
tremely low FSH concentrations, by isoproterenol as well as 
protein kinase activators; and second, one induced only by 
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slightly higher concentrations of FSH. These two mechanisms 
are referred to as heterologous and homologous desensitiza- 
tion, respectively. 
In the present work, we have assessed the roles of PKA and 
PKC and protein synthesis in FSH-induced desensitization of 
the tPA secretion of rat Sertoli cells in vitro, in order to test this 
hypothesis. 
2. Materials and methods 
2.1. Materials 
Cycloheximide, phorbol 12,13_dibutyrate (Pdbu), dibutyryl-CAMP 
(db-CAMP) and Soybean trypsin inhibitor were purchased from Sigma 
Chemical Co. (St. Louis, MO). Digitonin and Leibovitz’s L15 medium 
were obtained from Serva (Heidelberg, Germany). PKC inhibitor, 
PKCI (19-36) was obtained from Neosystem (Strasbourg, France), and 
PKA inhibitor (PKAI), PKI (6-22) amide from Gibco BRL. Equine 
FSH (eFSH) (CY1368: 864 x NIH-FSH-Sl in homologous equine 
RRA) was purified in our laboratory [6]. 
2.2. Isolation of rat seminiferous tubule cells 
Rat seminiferous tubule cells were prepared from 16 to 18-day-old 
rat testes (Wistar INRA 03) according to the method of Dorrington et 
al. [7l with the following modifications. Collagenase digestion was omit- 
ted and replaced by an additional mechanical dispersion performed just 
after inhibition of trypsin activity by a specific trypsin inhibitor (Soy- 
bean). Tubular cell preparations contained more than 75% Sertoli cells, 
about 17 f 5% germ cells and 4 f 2% myoid cells [8]. Identification of 
germ cells was achieved by staining with Trioxy hematein ferric and that 
of myoid cells by the alkaline phosphatase reaction [9]. 
2.3. Incubation of Sertoli cells and cell permeabilization 
Incubations of 0.5 x lo6 cells were performed in 300 ~1 of L15 me- 
dium and in 3 ml polystyrene tubes. The cells were preincubated for 2.5 
h in the presence of the desensitizing agents, then washed, and finally 
incubated for 4 h at 34°C in the presence of a submaximal dose (100 
ng/ml) of FSH. The activity of secreted tPA in the media was deter- 
mined as previously described [IO]. In the permeabilization experi- 
ments, digitonin was added 10 min before the preincubations with the 
desensitizing agents and was present during the 2.5 h preincubation 
period. It was removed during washings before the subsequent 4 h 
stimulation by FSH. The digitonin concentration required to permea- 
bilize the cells was adapted in each experiment by increasing its concen- 
tration until more than 95% of the cells were positive in the Trypan blue 
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test. The different inhibitors were added to the cells IO min before the 
addition of FSH for the preincubation. 
2.4. Assay of tissue type plasminogen activator activity 
The tPA content of incubation media was assayed by the ‘Z51-labeled 
fibrin digestion method as previously described [I 11. The tPA concen- 
tration promoting the conversion of plasminogen to plasmin was deter- 
mined from the release of radioactivity into the medium during fibrinol- 
ysis of insoluble radiolabeled fibrin by plasmin. Then, tPA activity was 
expressed as human tPA units, as determined with reference to a stand- 
ard preparation of human tPA [l2]. We have previously demonstrated 
the absence of tPA inhibitor in the medium of cells preincubated in the 
presence or absence of FSH [I]. 
2.5. Statistics 
Statistical analyses of the data were performed using a single mean 
Student’s t-test (Statview, Abacus Concepts, CA, USA), with P < 0.05 
considered to be statistically significant. All experiments were repeated 
at least three times. 
3. Results 
3.1. Pernteabilization of Sertoli cells 
In order to render Sertoli cells permeable to molecules such 
as peptides of approximately 2,000 Da, the digitonin permeabil- 
ization method was tested. The susceptibility of Sertoli cells in 
suspension to digitonin permeabilization was studied by scor- 
ing Trypan blue-positive cells as a function of digitonin concen- 
tration. A good permeabilization, assessed by more than 95% 
of Trypan blue-stained Sertoli cells, required a digitonin con- 
centration of about 0.006% for a Sertoli cell suspension at a 
density of 3. lo6 cells per ml. At digitonin concentrations higher 
than 0.012%, cell lysis was observed. 
The effect of 0.006% digitonin treatment on Sertoli cell bio- 
logical function was studied further. Fig. 1 shows that dig- 
itonin-treated cells can be stimulated by FSH, with no change 
in the pattern of desensitization of the tPA response compared 
to control cells (not permeabilized). In both intact and perme- 
abilized Sertoli cells, FSH concentrations from 0.3 to 5 @ml 
desensitized the subsequent PA production induced by 100 
ng/ml FSH, with a maximum inhibition of 60 + 5% at 5 @ml 
FSH. 
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Fig. I. Effect of cell permeabilization by digitonin on FSH stimulation 
and FSH-induced desensitization of tPA secretion. Sertoli cells were 
exposed (0) or not (0) to digitonin for IO min and subsequently prein- 
cubated for 2.5 h with the indicated concentrations of FSH. After a 
wash, Sertoli cells were then incubated for 4 h with FSH (100 &ml) 
and tPA levels were determined. Values are means ?r S.E.M. of tripli- 
cate determinations of a representative experiment. 
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Fig. 2. Effect of inhibitors of protein kinases on FSH stimulation and 
desensitization of tPA secretion by FSH in permeabilized rat Sertoli 
cells. (A) Effect of PKAI on FSH stimulated production of tPA. Perme- 
abilized Sertoli cells were preincubated for IO min in the presence 
(hatched bar) or absence (black bar) of I PM PKAI, subsequently 
stimulated for 4 h with 100 ng/ml FSH and tPA levels were determined. 
Values are means + S.E.M. of triplicate determinations of a representa- 
tive experiment. (B) Effect of PKCI on PKC activity. Permeabilized 
Sertoli cells were preincubated for IO min in the presence or absence 
of I ,LLM Pdbu and/or I PM PKCI, subsequently stimulated for 4 h with 
100 ng/ml FSH and tPA levels determined. Values are means f S.E.M. 
of triplicate determinations of a representative experiment. (C and D) 
Effect of PKAI and PKCI on FSH desensitization. Permeabilized Ser- 
toli cells were first incubated for IO min in the presence (0) or absence 
(0) of I PM PKAI (C) or I PM PKCI (D). Then, FSH was added at 
the indicated concentrations and preincubations were continued for 2.5 
h. After washing, the cells were then incubated for 4 h with 100 ng/ml 
FSH. tPA levels were determined and expressed as a percentage of the 
tPA production in the absence of FSH during the 2.5 h preincubation 
and with or without the protein kinase inhibitor used. Values are 
means f S.E.M. of triplicate determinations of a representative experi- 
ment. 
3.2. Effect of peptidic inhibitors of protein kinases A and C 
First, we verified the effectiveness and specificity of the pep- 
tide inhibitors of the protein kinases (Fig. 2A and B) in perme- 
abilized Sertoli cells stimulated for 4 h with 100 r&ml FSH. 
Fig. 2A shows that 1 ,uM of the PKA inhibitor (PKAI) 
abolished the FSH-stimulated tPA secretion, confirming the 
involvement of PKA in this action. The PKC inhibitor (PKCI) 
specificity was tested through its capacity to reverse the inhib- 
itory effect of a PKC activator, the phorbol ester Pdbu (Fig. 
2B). PKC activation by 1 ,uM Pdbu in Sertoli cells resulted in 
a 60% decrease in the tPA secretion induced by 100 @ml FSH. 
When PKCI (1 PM) was added together with Pdbu, the tPA 
secretion induced by 100 @ml FSH was restored, demonstrat- 
ing its inhibitory activity on PKC activity in permeabilized 
Sertoli cells. 
Preincubation of the cells with PKAI provoked a shift in the 
FSH doses required for the appearance of desensitization. In 
control cells, desensitization is promoted significantly by 0.3 
ng/ml FSH. In the presence of PKAI during preincubation, 
significant desensitization appeared for FSH doses higher than 
1 ng/ml (Fig. 2C). Moreover, PKAI pretreatment resulted in a 
significant decrease in the FSH-induced desensitization, its 
maximum observed at 5 ng/ml FSH being reduced from 65% 
to 50%. Preincubation with the peptidic inhibitor of PKC 
(1 PM) induced the same shift in the FSH doses able to desen- 
sitize (Fig. 2D), and the extent of desensitization was decreased 
from 60% to 40%. 
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Fig. 3. Effect of cycloheximide pretreatment on FSH stimulated tPA 
secretion. Sertoli cells were preincubated with (0) or without (0) 5&ml 
cycloheximide for 2.5 h. After washing, the cells were incubated for 
4 h with increasing concentrations of FSH and tPA levels were deter- 
mined. Control (m) consisted of the 4 h incubation with 5 @ml cyclo- 
heximide and 100 rig/ml FSH. Values are means f S.E.M. of triplicate 
determinations of a representative experiment. 
3.3. Effect of protein synthesis inhibition on the desensitization 
of the tPA response 
Sertoli cells were exposed to 5 &ml cycloheximide for 10 
min prior to the addition of desensitizating concentrations of 
the agents and during the 2.5 h preincubation. The cells were 
subsequently washed and challenged with 100 @ml FSH for 
4 h, after which time secreted tPA in the media was measured. 
Cycloheximide was completely removed by the cell washing, as 
assessed by the full tPA response recovered by Sertoli cells to 
FSH stimulation (Fig. 3). 
The perfect superimposition of the FSH stimulatory curves 
obtained in cells preincubated with or without 5 @ml cyclo- 
heximide shows that, the presence of cycloheximide alone 
during pretreatment did not modify the subsequent FSH-stimu- 
lated tPA production (Fig. 3). The same concentration of cyclo- 
heximide during the incubation period is, however, able to 
completely abolish tPA secretion induced by FSH 100 @ml, 
reflecting inhibition of tPA synthesis (Fig. 3). 
In the desensitization experiments, cycloheximide did not 
significantly affect the Pdbu- (Fig. 4A) or db-CAMP- (Fig. 4B) 
induced desensitization of the tPA response to subsequent FSH 
stimuation. 10 and 100 nM Pdbu induced 40% and 50% inhibi- 
tion, respectively, of the subsequent FSH-stimulated tPA secre- 
tion by Sertoli cells. Cycloheximide present before and during 
preincubation did not modify the extent of Pdbu-induced de- 
sensitization (Fig. 4A). Preincubation of the Sertoli cells with 
lo-’ M or 5 x lo-’ M dbcAMP promoted 25% and 40% inhibi- 
tion, respectively, of the subsequent 100 ng/ml FSH-stimulated 
tPA secretion. Cycloheximide did not alter this dbcAMP-in- 
duced desensitization (Fig. 4B). 
Cycloheximide affected the FSH-induced desensitization 
pattern of the tPA secretion subsequently stimulated by 100 
ng/ml FSH (Fig. 5). Cycloheximide present during preincuba- 
tion, without altering the appearance of desensitization pro- 
moted at the lowest FSH doses (< 1 ng/ml), significantly pre- 
vented the desensitization induced by higher FSH doses. A 
maximum of 40% of desensitization was observed with 0.6 
ng/ml FSH in the presence of cycloheximide, whereas 70% of 




We have previously described how low concentrations of 
FSH induced desensitization of Sertoli cells by measuring the 
secretion of tPA as an end point of this process [l]: it was not 
due to down-regulation of the receptors and did not affect the 
properties of the successive proteins involved in the transduc- 
tion pathway. Rather, it is due to receptor G, protein uncou- 
pling. We then demonstrated an heterologous component of 
the Sertoli cell tPA response desensitization under subsequent 
FSH stimulation: it can be promoted either with low FSH 
concentrations (lo-” M), isoproterenol, AMPc analogues or a 
PKC activator. This led us to postulate that protein kinases 
were involved in this process [l]. 
To lend further support to the involvement of these different 
kinases in FSH-induced desensitization and to try to discrimi- 
nate their respective roles, we used specific peptidic inhibitors 
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Fig. 4. Effect of cycloheximide on desensitization of tPA secretion 
induced by PKC or PKA activators. Sertoli cells were first incubated 
for 10 min with (hatched bars) or without (open bars) 5 &ml cyclo- 
heximide. Subsequently the indicated concentrations of Pdbu (A) or 
db-CAMP (B) were added and the oreincubations continued for 2.5 h. 
After washing, the cells were incubated for 4 h with 100 ng/ml FSH. 
tPA levels were determined and expressed as a percentage of the mean 
tPA levels produced after stimulation by 100 &ml FSH by not desen- 
sitized Sertoli cells preincubated with or without cycloheximide. Values 












z 60 - 
E 




I I ---I 
0.1 I IO 
FSH ng/ml 
Fig. 5. Effect of cycloheximide on desensitization of tPA secretion 
induced by FSH. Sertoli cells were first incubated for 10 min with (0) 
or without (0) 5 &ml cycloheximide. Subsequently the indicated con- 
centrations of FSH were added and the preincubations continued for 
2.5 h. After washing, the cells were incubated for 4 h with 100 ng/ml 
FSH. tPA levels were determined and expressed as a percentage of the 
mean tPA levels produced after stimulation by 100 ng/ml FSH by not 
desensitized Sertoli cells preincubated with or without cycloheximide. 
Values are means f S.E.M. of triplicate determinations of a representa- 
tive experiment. 
of PKA and PKC which interact with the substrate sites of the 
catalytic domains of these enzymes. At the concentration of 
1 PM used, these protein kinase inhibitors are effective in com- 
pletely blocking the activity of the kinases in a specific manner. 
Although protein kinase inhibitors prevent the onset of desen- 
sitization induced by 0.1-l ng/ml FSH, they only partially 
(20%) inhibit desensitization induced by higher FSH concentra- 
tions. These peptidic inhibitors clearly identify a first part of the 
desensitization as being PKA- and PKC-mediated. These re- 
sults can be linked to our previous studies on the effect of a 
pharmacological cell permeable kinase inhibitor H-9 (isoquino- 
line derivative) during the preincubation desensitizing period 
[l]. 510-’ M H-9 partially prevented FSH-induced desensitiza- 
tion, the maximum of desensitization being reduced from 65 to 
30%. At the concentration used, however, although H-9 mainly 
inhibits PKA it is also known to inhibit a number of other 
protein kinases, notably PKC. 
Nevertheless, none of these inhibitors was effective in com- 
pletely impeding FSH-induced desensitization. We can thus 
clearly distinguish an additional mechanism in the FSH-in- 
duced desensitization. This residual desensitization indicates 
that FSH regulates cell responsiveness by multiple mechanisms, 
one of them affected by inhibition of PKA and PKC and the 
other(s) not mediated by these protein kinases. This is in agree- 
ment with our previous result [l] showing that all the agents 
producing desensitization of the tPA response also stimulate 
the protein kinases but that this desensitization form is only a 
portion of FSH-induced desensitization. Indeed, an additional 
homologous component (FSH/FSH) is developed over the 
heterologous one. 
Since maximum FSH desensitization required pretreatment 
of the cells for 2.5 h, the possibility that this inhibition required 
protein synthesis was examined by the use of cycloheximide. 
Heterologous desensitization (45% of inhibition) induced by 
PKC activation with Pdbu was not altered in the presence of 
cycloheximide during the preincubation period. This confirms 
that the PKC-mediated desensitization of the FSH-stimulated 
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tPA response in Sertoli cells is independent of protein synthesis. 
Similarly, heterologous desensitization (40% of inhibition) in- 
duced by PKA activation with db-CAMP was unaffected by 
cycloheximide pretreatment. This allowed us to distinguish a 
PKA-mediated desensitization of the tPA response in Sertoli 
cells independent of protein synthesis. 
Although cycloheximide does not affect desensitization in- 
duced by 0.1-l t&ml FSH, it abolished desensitization pro- 
moted by l-5 ng/ml FSH (Fig. 5). This reflects the fact that 
there are two components in desensitization; one which is pro- 
moted by low FSH doses (0.1-l @ml) and which is not de- 
pendent of on-going proteins synthesis, and a second one which 
is promoted by higher FSH doses (2.5 and 5 ng/ml) and which 
appears to be dependent on protein synthesis. Concerning the 
second component, an effect of cycloheximide on tPA mRNA 
translation and synthesis can be put forward. It must be noted 
that cycloheximide alone during preincubation has no effect on 
subsequent FSH-stimulated tPA production by Sertoli cells, as 
confirmed by Fig. 3. However, inhibition by cycloheximide of 
the desensitization occurs at FSH concentrations that are able 
to slightly increase CAMP levels close to the threshold trigger- 
ing tPA production [lo]. The possibility that these FSH concen- 
trations, combined with cycloheximide during the preincuba- 
tion, were able to increase the levels of tPA mRNA and could 
promote an additional tPA secretion during subsequent incuba- 
tion, which would overlap the desensitization process studied, 
must be taken into consideration. A detailed functional analysis 
of this process at the level of the tPA mRNA is required to 
verify this hypothesis. 
Another hypothesis is the stimulation of a cytosolic proteic 
factor synthesis by desensitizing FSH doses, which would sub- 
sequently interfere with the FSH action. Protein kinase inhib- 
itors [13] or phosphodiesterases [14] are not likely candidates 
because the site of lesion of the desensitization observed is 
localized upstream of the production of CAMP [l]. Therefore, 
we suggest a direct involvement of this putative protein in the 
uncoupling of the receptor/G, protein, similarly to the arrestin- 
like proteins. 
The FSH receptor belongs to the wide superfamily of G 
protein-coupled receptors which exhibit such desensitization 
patterns, including of the more studied ones, the /3-adrenergic, 
muscarinic, rhodopsine, cholecystokinine and luteotropin re- 
ceptors [ 15-201. Although little is known concerning the short- 
term desensitization of the FSH receptor, it is reasonable to 
assume that its activity is controlled in a similar way. 
According to our results and those in the literature, the 
following working hypothesis can be suggested: FSH binds to 
its receptor under basal or slightly stimulating concentrations 
and induces the reduction in response of the Sertoli cells to its 
subsequent stimulation. This desensitization is characterized by 
an uncoupling of the FSH receptor and the G, protein. Trig- 
gered also by other Sertoli cell stimulators, the heterologous 
form of desensitization would involve the activation of protein 
kinases and phosphorylation of specific proteins. We can thus 
suggest hat the FSH receptor and/or G, protein could be tar- 
gets for these kinases. Although these studies reveal an uncou- 
pling between the FSH receptor and its transduction pathway 
and strongly imply a role for PKA and PKC in causing the 
heterologous desensitization, further studies will be necessary 
to establish the concept that direct phosphorylation of the FSH 
receptor by these kinases does occur in Sertoli cells in response 
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to FSH or other stimulators and triggers desensitization. Re- 
cently, the phosphorylation of the FSH receptor by FSH and 
PKC and its negative impact on the receptor function have been 
demonstrated, but in a cell line stably transfected with the rat 
FSH receptor cDNA [21]. Moreover, the molecular basis of the 
homologous component of the FSH-induced desensitization 
and the involvement of protein synthesis also require further 
investigation. 
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